CH617442A5 - - Google Patents

Download PDF

Info

Publication number
CH617442A5
CH617442A5 CH657874A CH657874A CH617442A5 CH 617442 A5 CH617442 A5 CH 617442A5 CH 657874 A CH657874 A CH 657874A CH 657874 A CH657874 A CH 657874A CH 617442 A5 CH617442 A5 CH 617442A5
Authority
CH
Switzerland
Prior art keywords
formula
compound
solvent
above meaning
hydroxy
Prior art date
Application number
CH657874A
Other languages
German (de)
English (en)
Inventor
John Joseph Partridge Jr
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH617442A5 publication Critical patent/CH617442A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH657874A 1973-05-21 1974-05-14 CH617442A5 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00362569A US3822254A (en) 1973-05-21 1973-05-21 Synthesis of 25-hydroxycholesterol

Publications (1)

Publication Number Publication Date
CH617442A5 true CH617442A5 (nl) 1980-05-30

Family

ID=23426617

Family Applications (1)

Application Number Title Priority Date Filing Date
CH657874A CH617442A5 (nl) 1973-05-21 1974-05-14

Country Status (9)

Country Link
US (1) US3822254A (nl)
JP (1) JPS5614679B2 (nl)
AT (1) AT343294B (nl)
BE (1) BE815252A (nl)
CH (1) CH617442A5 (nl)
DE (1) DE2424498C3 (nl)
FR (1) FR2236854B1 (nl)
GB (2) GB1445236A (nl)
NL (1) NL172956C (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5218700B2 (nl) * 1973-02-16 1977-05-24
US3928397A (en) * 1973-03-02 1975-12-23 Eisai Co Ltd New 5-cholestene derivatives and preparation thereof
US3959320A (en) * 1974-09-23 1976-05-25 The Upjohn Company Process and compounds
US3976636A (en) * 1974-10-10 1976-08-24 The Upjohn Company Process and compounds
US3994934A (en) * 1975-01-27 1976-11-30 The Upjohn Company Process for preparing Δ22 -25-oxy substituted sterol derivatives
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
US3994878A (en) * 1975-10-10 1976-11-30 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
CH628907A5 (en) * 1975-10-10 1982-03-31 Hoffmann La Roche Process for the preparation of 24,25-dihydroxycholesterol derivatives
US4038272A (en) * 1975-10-20 1977-07-26 Hoffmann-La Roche Inc. Stereospecific syntheses of 24r,25- and 24s,25-dihydroxycholesterol and alkanoyl derivatives thereof
JPS5371056A (en) * 1976-12-08 1978-06-24 Chugai Pharmaceut Co Ltd Steroid derivs.
JPS53144563A (en) * 1977-05-19 1978-12-15 Chugai Pharmaceut Co Ltd Preparation of steroid derivatives
CA1138859A (en) * 1979-02-15 1983-01-04 Teijin Limited 25-hydroxy-24-oxocholestane derivatives and preparation thereof
CH644873A5 (de) * 1980-02-12 1984-08-31 Hoffmann La Roche Verfahren zur herstellung von cholesterinderivaten.
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
US8399441B2 (en) * 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
MX2016008459A (es) 2013-12-24 2016-10-14 Univ Virginia Commonwealth Usos de sulfatos de colesterol oxigenados (soc).
PT3494125T (pt) 2016-08-02 2022-07-07 Durect Corp Composições compreendendo 5-colesten-3, 25-diol, 3-sulfato (25hc3s), ou seu sal farmaceuticamente aceitável, e, pelo menos, um oligossacárido cíclico
CN111320663B (zh) * 2018-12-13 2023-01-24 上海医药工业研究院 一种24-胆烯烯酸乙酯中间体的制备方法
EP3906247A4 (en) * 2019-07-09 2022-10-12 Fermenta Biotech Limited SYNTHESIS OF CHOLESTEROL AND VITAMIN D3 FROM PHYTOSTEROLS
CN111138512A (zh) * 2019-12-27 2020-05-12 郑州手性药物研究院有限公司 一种合成25-羟基胆固醇中间体的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1261291A (en) * 1968-07-01 1972-01-26 Wisconsin Alumni Res Found Calciferol compounds and process of preparing the same
US3846455A (en) * 1972-05-22 1974-11-05 Eisai Co Ltd Process for the preparation of 25-hydroxy-cholesterol and esters thereof

Also Published As

Publication number Publication date
DE2424498C3 (de) 1981-04-02
DE2424498A1 (de) 1974-12-12
NL172956B (nl) 1983-06-16
FR2236854B1 (nl) 1977-10-21
US3822254A (en) 1974-07-02
NL172956C (nl) 1983-11-16
GB1445237A (en) 1976-08-04
BE815252A (fr) 1974-11-20
JPS5614679B2 (nl) 1981-04-06
AT343294B (de) 1978-05-26
GB1445236A (en) 1976-08-04
ATA416374A (de) 1977-09-15
NL7406748A (nl) 1974-11-25
DE2424498B2 (de) 1980-06-04
JPS5018458A (nl) 1975-02-26
FR2236854A1 (nl) 1975-02-07

Similar Documents

Publication Publication Date Title
DE2424498C3 (de) Verfahren zur Herstellung von 25-Hydroxycholesterin
EP0000533B1 (de) N-Substituierte 9,10-Dihydrolysergsäureester sowie ein Verfahren zu deren Herstellung
EP0004621A2 (de) Verfahren zur mehrstufigen Synthese von Zeaxanthin und Alloxanthin über Cyclohexanon- und Cyclohexanolderivate; Cyclohexanon- und Cyclohexanolderivate
DE2607322A1 (de) Verfahren zur herstellung von 1 alpha, 25-dihydroxycholecalciferol
DE1958600A1 (de) Neue Isoxazolderivate und deren Herstellung
DE2426528C3 (de) Verfahren zur Herstellung von 25-Hydroxycholesterin, sowie 20(S)-25-Hydroxycholesterin und dessen Derivate
CH628907A5 (en) Process for the preparation of 24,25-dihydroxycholesterol derivatives
DE2347172A1 (de) Prostaglandin e tief 1-synthese
CH626096A5 (nl)
Marshall et al. Synthesis of cyclodecenes from bicyclo [5.3. 1] undecanediol derivatives
DE2253089C2 (de) 9-Oxo-9,10,seco-östran-Derivate und Verfahren zur Herstellung dieser Verbindungen und von 9-Oxo-D-homo-9,10-seco-östran-Derivaten
DE1949793A1 (de) Neue Indanderivate und deren Herstellung
DE1618507B2 (de) desA-Steroiden und Verfahren zu deren Herstellung
DE3244272A1 (de) (omega),(omega)-diacyloxy-2,6-dimethyl-octatriencarbonsaeureester und -aldehyde, verfahren zu ihrer herstellung und verwendung zur synthese von terpenverbindungen
WO2009141110A1 (de) Verfahren zur selektiven synthese von 3-alpha-hydroxychlormadinonacetat
DE2331044A1 (de) Diphenylmethan-derivate und verfahren zu deren herstellung
DE2246867A1 (de) Tetrahydroxy-bicyclo- eckige klammer auf 3.3.0 eckige klammer zu -octane
DE2222544C3 (de) Neue 16,17-Secoöstradi- und triene Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel
AT260436B (de) Verfahren zur Herstellung von 3-Oxo-13β-alkyl-4-gonenen
DE2749104C2 (de) Verfahren zur Herstellung von δ↑15↑ -Steroiden
CH627764A5 (en) Process for the preparation of cholestadiene derivatives
CH617424A5 (nl)
DE19914019C1 (de) Verfahren zur Herstellung von 4,4-Dimethyl-3beta-hydroxypregna-8,14-dien-21-carbonsäureestern, deren Verwendung und Zwischenprodukte im Verfahren
DE2349260A1 (de) Synthese aromatischer steroide
CH635317A5 (de) Derivate des 8-dehydro-vitamins-a sowie verfahren zu deren herstellung.

Legal Events

Date Code Title Description
PL Patent ceased